1. 1A.08: GENETIC MARKERS IN CARDIAC RESYNCHRONIZATION THERAPY TREATMENT SUCCESS. (June 2015) Authors: Schmitz, B.; De Maria, R.; Gatsios, D.; Chrysanthakopoulou, T.; Landolina, M.; Gasparini, M.; Campolo, J.; Parolini, M.; Sanzo, A.; Galimberti, P.; Lenders, M.; Brand, E.; Parodi, O.; Lunati, M.; Brand, S.M. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 292 FACTORS AFFECTING HEALTH CARE PROVIDER CHOICE IN SIEM REAP, CAMBODIA. (1st January 2006) Authors: Schmitz, B.; Sakhem, N.; Bezruchka, S.; Morgan, M. S. Journal: Journal of investigative medicine Issue: Volume 54:Number 1(2006) Page Start: S130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomized, double‐blind, phase III, multicentre study to evaluate the safety and efficacy of BF‐200 ALA (Ameluz®) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the BF‐RhodoLED® lamp. (1st October 2016) Authors: Reinhold, U.; Dirschka, T.; Ostendorf, R.; Aschoff, R.; Berking, C.; Philipp‐Dormston, W.G.; Hahn, S.; Lau, K.; Jäger, A.; Schmitz, B.; Lübbert, H.; Szeimies, R.‐M. Journal: British journal of dermatology Issue: Volume 175:Number 4(2016) Page Start: 696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized, double‐blind, phase III, multicentre study to evaluate the safety and efficacy of BF‐200 ALA (Ameluz®) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the BF‐RhodoLED® lamp3. (25th June 2016) Authors: Reinhold, U.; Dirschka, T.; Ostendorf, R.; Aschoff, R.; Berking, C.; Philipp‐Dormston, W.G.; Hahn, S.; Lau, K.; Jäger, A.; Schmitz, B.; Lübbert, H.; Szeimies, R.‐M. Journal: British journal of dermatology Issue: Volume 175:Number 4(2016) Page Start: 696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A randomized, intraindividual, non‐inferiority, Phase III study comparing daylight photodynamic therapy with BF‐200 ALA gel and MAL cream for the treatment of actinic keratosis. (14th August 2018) Authors: Dirschka, T.; Ekanayake‐Bohlig, S.; Dominicus, R.; Aschoff, R.; Herrera‐Ceballos, E.; Botella‐Estrada, R.; Hunfeld, A.; Kremser, M.; Schmitz, B.; Lübbert, H.; Puig, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 2(2019) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF‐200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. (1st August 2018) Authors: Morton, C.A.; Dominicus, R.; Radny, P.; Dirschka, T.; Hauschild, A.; Reinhold, U.; Aschoff, R.; Ulrich, M.; Keohane, S.; Ekanayake‐Bohlig, S.; Ibbotson, S.; Ostendorf, R.; Berking, C.; Gröne, D.; Schulze, H.J.; Ockenfels, H.M.; Jasnoch, V.; Kurzen, H.; Sebastian, M.; Stege, H. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF‐200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy3. (16th May 2018) Authors: Morton, C.A.; Dominicus, R.; Radny, P.; Dirschka, T.; Hauschild, A.; Reinhold, U.; Aschoff, R.; Ulrich, M.; Keohane, S.; Ekanayake‐Bohlig, S.; Ibbotson, S.; Ostendorf, R.; Berking, C.; Gröne, D.; Schulze, H.J.; Ockenfels, H.M.; Jasnoch, V.; Kurzen, H.; Sebastian, M.; Stege, H. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. BF‐200 ALA gel vs. MAL cream for BCC. (1st August 2018) Authors: Morton, C.A.; Dominicus, R.; Radny, P.; Dirschka, T.; Hauschild, A.; Reinhold, U.; Aschoff, R.; Ulrich, M.; Keohane, S.; Ekanayake‐Bohlig, S.; Ibbotson, S.; Ostendorf, R.; Berking, C.; Gröne, D.; Schulze, H.J.; Ockenfels, H.M.; Jasnoch, V.; Kurzen, H.; Sebastian, M.; Stege, H. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: e91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BF‐200 ALA gel vs. MAL cream for BCC. (24th August 2018) Authors: Morton, C.A.; Dominicus, R.; Radny, P.; Dirschka, T.; Hauschild, A.; Reinhold, U.; Aschoff, R.; Ulrich, M.; Keohane, S.; Ekanayake‐Bohlig, S.; Ibbotson, S.; Ostendorf, R.; Berking, C.; Gröne, D.; Schulze, H.J.; Ockenfels, H.M.; Jasnoch, V.; Kurzen, H.; Sebastian, M.; Stege, H. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: e91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. BF‐200 ALA凝胶与MAL乳膏治疗BCC的对比. (1st August 2018) Authors: Morton, C.A.; Dominicus, R.; Radny, P.; Dirschka, T.; Hauschild, A.; Reinhold, U.; Aschoff, R.; Ulrich, M.; Keohane, S.; Ekanayake‐Bohlig, S.; Ibbotson, S.; Ostendorf, R.; Berking, C.; Gröne, D.; Schulze, H.J.; Ockenfels, H.M.; Jasnoch, V.; Kurzen, H.; Sebastian, M.; Stege, H. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: e111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗